Filing Details
Roivant Sciences Ltd. (NASDAQ:ROIV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 09, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ROIV
Roivant Sciences Ltd. (ROIV) Files Quarterly Report for Q0
Roivant Sciences Ltd. (NASDAQ:ROIV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 09, 2026.
At publication ·
What changed
Roivant Sciences Ltd. (NASDAQ:ROIV) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Roivant Sciences filed its quarterly report on November 09, 2026, with a current stock price of $38.88 and market capitalization of $14.8 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on recent business performance and emerging trends.
- Public companies file multiple SEC document types including annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4).
- Investors can access all Roivant Sciences SEC filings through the SEC's EDGAR database and set up alerts for material developments.
Market Context
Roivant Sciences Ltd.'s stock currently trades at $38.88 with a market capitalization of $14.8B.
The 10-Q provides Roivant Sciences Ltd.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Roivant Sciences Ltd. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ROIV Stock Page
Frequently Asked Questions
Where can I read ROIV's SEC filings?
Browse all filings on our ROIV SEC filings page.
What types of SEC filings does Roivant Sciences Ltd. file?
Public companies like Roivant Sciences Ltd. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Loading related coverage…